ALNT.NASDAQAllient INC

Form 4: Allient Inc. Executive Kenneth May Reports Acquisition of Common Stock and Restricted Shares

Sentiment:

SEC Form 4 Filing


Kenneth Arthur May, Chief Technology Officer of Allient Inc., reports acquiring common stock and restricted shares through grants under the company's 2017 Omnibus Incentive Plan.

Summary

  • On March 5, 2024, Kenneth Arthur May, the Chief Technology Officer of Allient Inc. (ALNT), reported transactions involving Allient Inc. common stock.
  • May acquired 1,412 time-based restricted shares at $30 each, which vest in three equal installments on April 1, 2025, 2026, and 2027.
  • He also acquired 1,412 performance-based restricted shares at $30 each, vesting over three years based on performance goals set for the year ending December 31, 2024.
  • Additionally, May acquired 1,979 restricted shares at $30 each, vesting over two years, based on previously established performance goals under the company's Long-Term Incentive Plan.
  • Following these transactions, May directly owns 15,865 shares of common stock and indirectly owns 794 shares through an ESOP Trust.

Sentiment

Score: 6

Explanation: The document reflects standard executive compensation practices. It's neutral in tone and doesn't indicate any significant positive or negative developments.

Positives

  • The acquisition of restricted shares aligns the executive's interests with the long-term performance of the company.
  • The vesting schedules for the restricted shares encourage continued service and achievement of performance goals.
  • The grants are part of the company's established incentive plans, suggesting a consistent approach to executive compensation.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the restricted shares suggest a focus on long-term performance and retention of the executive.

Industry Context

Executive compensation through stock and restricted share grants is a common practice in publicly traded companies to align management's interests with those of shareholders. The specific terms of the grants, such as vesting schedules and performance metrics, are tailored to the company's specific goals and industry practices.

Comparison to Industry Standards

  • Stock grants are a common component of executive compensation packages in the technology and manufacturing sectors, often used by companies like Allient's competitors such as AMETEK, Inc. and Teledyne Technologies Incorporated.
  • Vesting schedules of three years for time-based grants and performance-based metrics tied to annual goals are typical industry practices, similar to those used by Analog Devices and Texas Instruments.
  • The use of an Omnibus Incentive Plan is a standard approach for administering equity-based compensation, aligning with the practices of companies like Rockwell Automation and Emerson Electric Co.

Stakeholder Impact

  • The grants of restricted shares could have a positive impact on shareholders by aligning executive compensation with company performance.
  • The vesting schedules may encourage employee retention and motivation.

Key Dates

DateDescription
03/05/2024Date of the reported transactions (acquisition of common stock and restricted shares).
03/07/2024Date of signature on the Form 4 filing.
04/01/2025First vesting date for one-third of the time-based restricted shares.
04/01/2026Second vesting date for one-third of the time-based restricted shares.
04/01/2027Final vesting date for one-third of the time-based restricted shares.
12/31/2024End of the performance period for the performance-based restricted shares.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.